Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury
Authors not listed
University of Washington · 2024
Abstract
The investigators would like to improve our understanding of how early intervention with the use of bladder chemodenervation can preserve bladder function in those with a new SCI. Although detrimental cystometric and tissue changes are known to occur, often within 3 months after SCI, the investigators seek to document the time course of these changes and the range of severity of those changes in both those participants that receive prophylactic treatment and those who do not.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2024). Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury. <em>University of Washington</em>. https://clinicaltrials.gov/study/NCT06793683
Vancouver
Anonymous. Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury. University of Washington. 2024.
BibTeX
@misc{anon2024EarlyD,
title = {Early Detrusor Chemodenervation to Preserve Bladder Compliance and Longevity After Spinal Cord Injury},
author = {Anonymous},
journal = {University of Washington},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The University of Texas Medical Branch, Galveston 2014
Open access · US-GOV
IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial
Sengkang General Hospital 2023
Open access · US-GOV
Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore
University of Birmingham 2014
Open access · US-GOV
BREVITY: A Phase II Study of Brentuximab Vedotin Using a Response Adapted Design in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity
Kaiser Permanente 2019
Open access · US-GOV
Randomized Trial to Reduce Sitting Time and Improve Cardiometabolic Health in Obese Older Adults
Healthcare Technologies and Methods, LLC 2018
Open access · US-GOV
Interactive Technology for Hearing Aid Education and Acceptance
University of Waterloo 2017
Open access · US-GOV